Brodnem-IC Injection
Marketer
Nurtureplus Biotech Private Limited
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Brodnem-IC Injection
Combiflox Injection is a dual-antibiotic formulation indicated for the treatment of serious bacterial infections. It combats infectious microorganisms, thus preventing infection spread. Administration must be solely by a qualified healthcare provider. Strict adherence to the prescribed dosage schedule is crucial; complete the entire course even with symptom improvement. Commonly reported adverse effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain), typically resolving spontaneously. However, intensified side effects warrant immediate physician consultation. Seek urgent medical attention for allergic reactions manifested by skin rashes, itching, swelling, or respiratory distress. Prior to commencing treatment, inform your doctor of all current medications and pre-existing health conditions. Pregnant or lactating individuals require prior physician approval. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from operating vehicles if experiencing somnolence or dizziness.
Uses of Brodnem-IC Injection
Life-threatening bacterial infestations
Major Benefits of Brodnem-IC Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Brodnem-IC Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Brodnem-IC Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Brodnem-IC Injection works:
Brodnem-IC Injection unites Imipenem, a bacterial growth inhibitor, with Cilastatin, a dehydropeptidase I inhibitor. Imipenem's mechanism involves disrupting bacterial cell wall synthesis, a critical process for bacterial viability. Cilastatin safeguards Imipenem's efficacy by neutralizing dehydropeptidase I, an enzyme that would otherwise rapidly inactivate it, thus extending Imipenem's therapeutic presence within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Brodnem-IC Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Brodnem-IC Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Brodnem-IC Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Brodnem-IC Injection may induce adverse reactions impacting driving capabilities. Some medication-related side effects, including hallucinations (visual, auditory, or sensory), can impair driving ability in certain individuals.
KidneyCAUTION
Exercise caution when administering Brodnem-IC Injection to individuals with impaired renal function. Dosage modification of Brodnem-IC Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Brodnem-IC Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Brodnem-IC Injection :
Omit a Brodnem-IC Injection dose? Seek medical advice immediately.
Facts to Know About Brodnem-IC Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Anti-Infective Agents |
3,018 People bought this recently